Three questions with BioAffinity CEO Maria Zannes

PUBLISHED ON October 23, 2015

San Antonio Business Journal (October 23, 2015) San Antonio’s BioAffinity Technologies was invited to present its novel technology for the detection and diagnosis of early-stage lung cancer at the 2015 Pharmaceutical/Medtech Dealmaking Symposium in Chicago last week.

read more